Home / Treatments / Prescription Drugs
Prescription Drugs denials: what the review data shows
Independent reviewers have decided 11,948 published cases where an insurer denied prescription drugs — and they overturned the insurer 60.3% of the time. If your denial is in this category, the odds say: appeal.
Published decisions
11,948
2001–2026
Overturned
60.3%
7,205 denials reversed
By denial reason
The excuse on the letter changes the odds — and the counter-strategy.
| Denial reason | Decisions | Overturned |
|---|---|---|
| medical necessity | 10,653 | 61.8% |
| experimental / investigational | 1,295 | 48.3% |
Within this category
Subcategories with at least 15 published decisions.
| Subcategory | Decisions | Overturned |
|---|---|---|
| Other | 1,825 | 47.6% |
| Weight Control | 1,582 | 86.3% |
| Anti-virals | 1,351 | 81.4% |
| Hormones | 971 | 43% |
| Biologics | 527 | 78.2% |
| Skin Treatment | 519 | 69% |
| Botox Injection | 518 | 57.9% |
| Pain Medication | 413 | 32.4% |
| Arthritis Rx | 400 | 56% |
| IVIG Therapy | 385 | 49.1% |
| Non-FDA Approved Use | 384 | 43.5% |
| Diabetic Medication | 288 | 74.7% |
| Anti-inflammatories | 266 | 52.6% |
| Digestion/GI Rx | 229 | 79.5% |
| Antibiotics | 202 | 41.6% |
| Formulary v Non Form | 197 | 39.6% |
| Cardiac Rx | 180 | 38.9% |
| Analgesics | 179 | 20.1% |
| Migraine Rx | 172 | 83.1% |
| Neuromuscular RX | 111 | 81.1% |
How to use this in your appeal
These are outcomes from California’s external review program — an independent physician panel that binds the insurer. Every state has an equivalent process, and internal appeals succeed even more often. Cite the category outcome when you appeal: reviewers routinely find that denials like yours didn’t hold up.
SOURCE: CALIFORNIA DMHC INDEPENDENT MEDICAL REVIEW OUTCOMES (CHHS OPEN DATA) · DERIVED AGGREGATE STATISTICS ONLY · METHODOLOGY
Not legal or medical advice. Coverage Rights is a self-help tool that helps you prepare your own appeal. For advice about your specific situation, talk to a licensed attorney or your doctor.